Inovio Pharmaceuticals Inc (INO)
Inovio - FDA Accepts for Review INOVIOs BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
Inovio - FDA Accepts for Review INOVIOs BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General